Richard Sykes's most recent trade in Dycom Industries, Inc. was a trade of 781 Restricted Stock Units done . Disclosure was reported to the exchange on May 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 781 | 21,396 | - | 0 | Restricted Stock Units | |
| PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2024 | 9,000 | 9,000 | - | - | Employee Stock Option (Right to Buy) | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 1,014 | 20,615 | - | 0 | Restricted Stock Units | |
| PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jul 2023 | 9,000 | 9,000 | - | - | Employee Stock Option (Right to Buy) | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 1,747 | 19,601 | - | 0 | Restricted Stock Units | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Sale of securities on an exchange or to another person at price $ 92.35 per share. | 21 Dec 2022 | 2,000 | 0 (0%) | 0% | 92.4 | 184,700 | Common Stock |
| PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2022 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2022 | 1,679 | 19,854 | - | 0 | Restricted Stock Units | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 82.96 per share. | 02 May 2022 | 287 | 18,175 (0%) | 0% | 83.0 | 23,810 | Common Stock |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 84.29 per share. | 31 Jan 2022 | 282 | 17,888 (0%) | 0% | 84.3 | 23,770 | Common Stock |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 81.55 per share. | 01 Nov 2021 | 292 | 17,606 (0%) | 0% | 81.6 | 23,813 | Common Stock |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 68.01 per share. | 02 Aug 2021 | 356 | 17,314 (0%) | 0% | 68.0 | 24,212 | Common Stock |
| PDS Biotechnology Corporation | Richard Brook Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2021 | 9,000 | 9,000 | - | - | Stock Option (Right to Buy) | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2021 | 1,905 | 16,958 | - | 0 | Restricted Stock Units | |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 96.48 per share. | 03 May 2021 | 240 | 15,053 (0%) | 0% | 96.5 | 23,155 | Common Stock |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 87.13 per share. | 01 Feb 2021 | 266 | 14,813 (0%) | 0% | 87.1 | 23,177 | Common Stock |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 64.61 per share. | 26 Oct 2020 | 358 | 14,547 (0%) | 0% | 64.6 | 23,130 | Common Stock |
| Dycom Industries, Inc. | Richard K. Sykes | Director | Grant, award, or other acquisition of securities at price $ 43.46 per share. | 27 Jul 2020 | 533 | 14,189 (0%) | 0% | 43.5 | 23,164 | Common Stock |